AVERITAS Trademark

Trademark Overview

On Thursday, December 15, 2022, a trademark application was filed for AVERITAS with the United States Patent and Trademark Office. The USPTO has given the AVERITAS trademark a serial number of 97978838. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, April 2, 2025. This trademark is owned by Averitas Pharma, Inc.. The AVERITAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, and neurological diseases and disorders
averitas

General Information

Serial Number97978838
Word MarkAVERITAS
Filing DateThursday, December 15, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, April 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral, metabolic, endocrine, and neurological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 21, 2023
Primary Code005
First Use Anywhere DateTuesday, November 27, 2018
First Use In Commerce DateFriday, March 29, 2019

Trademark Owner History

Party NameAveritas Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameAveritas Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Trademark Events

Event DateEvent Description
Monday, December 19, 2022NEW APPLICATION ENTERED
Tuesday, February 21, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, January 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 14, 2023ASSIGNED TO EXAMINER
Tuesday, February 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 20, 2023SOU EXTENSION 1 FILED
Tuesday, February 21, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 20, 2023SOU EXTENSION 1 GRANTED
Monday, November 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 2, 2024DIVISIONAL REQUEST RECEIVED
Thursday, May 2, 2024SOU EXTENSION 3 FILED
Thursday, May 2, 2024SOU EXTENSION 2 FILED
Thursday, May 2, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024SOU EXTENSION 2 GRANTED
Thursday, May 2, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, May 2, 2024TEAS REQUEST TO DIVIDE RECEIVED
Friday, May 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 10, 2024ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Wednesday, August 7, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 5, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, September 5, 2024SOU EXTENSION 3 GRANTED
Thursday, May 2, 2024USE AMENDMENT FILED
Thursday, August 8, 2024ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Thursday, September 5, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 11, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2024SU - NON-FINAL ACTION - WRITTEN
Wednesday, September 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 20, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, November 20, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, March 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 15, 2025ASSIGNED TO LIE
Friday, March 21, 2025FINAL REFUSAL E-MAILED
Friday, March 21, 2025SU - FINAL REFUSAL - WRITTEN
Tuesday, April 1, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 1, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, April 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 2, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 2, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 21, 2025NOTIFICATION OF FINAL REFUSAL EMAILED

Related Keywords

averitas neurological diseases disorders endocrine metabolic preparations treatment viral pharmaceutical